AMPK and p53 help cells through lean times

Carson C Thoreen1, David M Sabatini

  • 1The Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, Massachusetts 02142, USA.

Cell Metabolism
|August 2, 2005
PubMed

Insights

Cells facing nutrient scarcity halt division or undergo apoptosis. AMP-activated kinase activates the tumor suppressor p53, mediating this crucial cellular response to low nutrient conditions.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Cells respond to low nutrient conditions by arresting cell division or undergoing apoptosis.
  • Understanding the molecular mechanisms behind these responses is critical for cell survival and disease research.

Purpose of the Study:

  • To elucidate the role of AMP-activated kinase in mediating cellular responses to low nutrient conditions.
  • To investigate the mechanism by which AMP-activated kinase influences cell division and apoptosis.

Main Methods:

  • The study likely involved cell culture experiments under varying nutrient levels.
  • Analysis of protein phosphorylation and activation states, specifically focusing on AMP-activated kinase and p53.
  • Investigated the impact of AMP-activated kinase activity on cell cycle progression and apoptotic markers.

Main Results:

  • AMP-activated kinase (AMPK) was identified as a key mediator of cellular response to nutrient deprivation.
  • AMPK phosphorylates and activates the tumor suppressor p53.
  • Activation of p53 by AMPK leads to cell cycle arrest or apoptosis in low nutrient environments.

Conclusions:

  • AMP-activated kinase plays a pivotal role in cellular adaptation to nutrient stress.
  • The phosphorylation and activation of p53 by AMPK is a central mechanism controlling cell fate under nutrient scarcity.
  • This pathway represents a significant target for understanding and potentially treating diseases related to metabolic stress.

Related Concept Videos

DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...